Statin ingredient specific
retiredURL
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.7
Version20170727
PublisherTJC EH StewardDate2017-07-27T01:00:03-04:00Purpose(Clinical Focus: HMG-CoA reductase inhibitors (statin) drugs as independent ingredients for use in noting the most general idea of statin ingredients. Initial use is for representation of a medication "not done". The desire is to have a single choice.),(Data Element Scope: Medication order or discharge NOT DONE),(Inclusion Criteria: Only single ingredient, ingredient-level representation of statin drugs),(Exclusion Criteria: None)
Expansion
| Code | Display | System |
|---|---|---|
| 6472 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 83367 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 36567 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 301542 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 861634 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 41127 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 42463 | http://www.nlm.nih.gov/research/umls/rxnorm |